Renaissance Technologies LLC Has $4.26 Million Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Renaissance Technologies LLC cut its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 18.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 218,100 shares of the company's stock after selling 48,200 shares during the period. Renaissance Technologies LLC owned about 0.18% of Privia Health Group worth $4,264,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Barclays PLC increased its position in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after purchasing an additional 158,188 shares in the last quarter. Geode Capital Management LLC boosted its stake in Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock worth $43,986,000 after purchasing an additional 23,178 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Privia Health Group during the third quarter worth $263,000. Franklin Resources Inc. increased its stake in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after buying an additional 28,480 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after buying an additional 14,641 shares in the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Down 1.2 %

PRVA traded down $0.29 during trading on Friday, hitting $23.17. The company had a trading volume of 383,161 shares, compared to its average volume of 775,054. The firm's 50-day moving average price is $23.64 and its 200 day moving average price is $21.87. The company has a market capitalization of $2.81 billion, a PE ratio of 231.72, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PRVA. Barclays upped their price objective on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, April 10th. Piper Sandler upped their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Stephens reiterated an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Truist Financial raised their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Finally, Canaccord Genuity Group raised their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $27.14.

Insider Transactions at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 10.70% of the stock is owned by insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.